BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32586572)

  • 1. Initial Treatment of Early Stage and Low Tumor Burden Follicular Lymphoma.
    Cohen JB; Kahl BS
    Hematol Oncol Clin North Am; 2020 Aug; 34(4):663-672. PubMed ID: 32586572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial Treatment of High Tumor Burden Follicular Lymphoma.
    Freeman CL; Sehn LH
    Hematol Oncol Clin North Am; 2020 Aug; 34(4):673-687. PubMed ID: 32586573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Open questions in watchful waiting for follicular lymphoma.
    Sorigue M; Sancho JM; Ribera JM
    Br J Haematol; 2017 Nov; 179(4):679-681. PubMed ID: 27390920
    [No Abstract]   [Full Text] [Related]  

  • 4. Front-line management of non-Hodgkin lymphoma in Australia. Part 1: follicular lymphoma.
    Trotman J; Cheah CY; Marlton P; Opat S
    Intern Med J; 2019 Apr; 49(4):422-433. PubMed ID: 30230156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is observation dead in follicular lymphoma? Still appropriate.
    Jacobson CA; Freedman AS
    J Natl Compr Canc Netw; 2015 Mar; 13(3):367-70. PubMed ID: 25736012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment levels of serum soluble interleukin-2 receptor are useful in selecting the treatment regimen for newly diagnosed advanced-stage follicular lymphoma with low tumor burden.
    Nozaki K; Sugahara H; Ueda S; Ishikawa J; Karasuno T; Iida M; Kamae T; Moriyama Y; Kawakami M; Kosugi S; Nakagawa M; Azenishi Y; Sakaniwa R; Kitamura T; Shibayama H
    Int J Hematol; 2021 Aug; 114(2):217-221. PubMed ID: 33847924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is observation dead in follicular lymphoma? No, but the apoptosis pathway has been activated.
    Fisher RI; Khan N
    J Natl Compr Canc Netw; 2015 Mar; 13(3):363-6. PubMed ID: 25736011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody Therapy Maintenance in Follicular Lymphoma.
    Golfier C; Salles G
    Hematol Oncol Clin North Am; 2020 Aug; 34(4):689-699. PubMed ID: 32586574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follicular lymphoma: first-line treatment without chemotherapy for follicular lymphoma.
    Reagan PM; Friedberg JW
    Curr Treat Options Oncol; 2015 Jul; 16(7):32. PubMed ID: 26031546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes following watchful waiting for stage II-IV follicular lymphoma patients in the modern era.
    Nastoupil LJ; Sinha R; Byrtek M; Ziemiecki R; Zhou X; Taylor M; Friedberg JW; Link BK; Cerhan JR; Dawson K; Flowers CR
    Br J Haematol; 2016 Mar; 172(5):724-34. PubMed ID: 26729445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individualized management of follicular lymphoma.
    Bai B; Huang HQ
    Chin Clin Oncol; 2015 Mar; 4(1):7. PubMed ID: 25841714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and treatment of follicular lymphoma.
    Hitz F; Ketterer N; Lohri A; Mey U; Pederiva S; Renner C; Taverna C; Hartmann A; Yeow K; Bodis S; Zucca E
    Swiss Med Wkly; 2011; 141():w13247. PubMed ID: 21815111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in Treatment of Follicular Lymphoma.
    Luminari S; Trotman J; Federico M
    Cancer J; 2020; 26(3):231-240. PubMed ID: 32496456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Management strategy for follicular lymphoma].
    Fukuhara N
    Rinsho Ketsueki; 2017; 58(10):2020-2025. PubMed ID: 28978844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frontline intensive chemotherapy improves outcome in young, high-risk patients with follicular lymphoma: pair-matched analysis from the Czech Lymphoma Study Group Database.
    Procházka V; Papajík T; Janíková A; Belada D; Kozák T; Šálek D; Sýkorová A; Móciková H; Campr V; Dlouhá J; Langová K; Fürst T; Trněný M
    Leuk Lymphoma; 2017 Mar; 58(3):601-613. PubMed ID: 27666539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yttrium 90-ibritumomab tiuxetan plus rituximab maintenance as initial therapy for patients with high-tumor-burden follicular lymphoma: a Wisconsin Oncology Network study.
    Rajguru S; Kristinsdottir T; Eickhoff J; Peterson C; Meyer CM; Traynor AM; Kahl BS
    Clin Adv Hematol Oncol; 2014 Aug; 12(8):509-15. PubMed ID: 25356575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current approaches and future perspectives for advanced-stage follicular lymphoma with a low tumor burden.
    Fukuhara N; Ishizawa K
    Jpn J Clin Oncol; 2019 Apr; 49(4):306-310. PubMed ID: 30715424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and Biological Prognostic Factors in Follicular Lymphoma.
    Patel AA; Smith SM
    Hematol Oncol Clin North Am; 2020 Aug; 34(4):647-662. PubMed ID: 32586571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Low grade lymphoma: research progress and questions about treatment].
    Ishizawa K
    Rinsho Ketsueki; 2015 Oct; 56(10):2039-46. PubMed ID: 26458443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial.
    Trotman J; Barrington SF; Belada D; Meignan M; MacEwan R; Owen C; Ptáčník V; Rosta A; Fingerle-Rowson GR; Zhu J; Nielsen T; Sahin D; Hiddemann W; Marcus RE; Davies A;
    Lancet Oncol; 2018 Nov; 19(11):1530-1542. PubMed ID: 30309758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.